Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 136Gynecologic 26Thoracic 4Genitourinary 4Sarcoma 2Other 2Head & Neck 2Gastrointestinal 2Tumor-Agnostic 1Endocrine 1CNS 1

Conditions

Sexual Dysfunctions, Psychological 1Progesterone Resistance 1Obesity 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Breast Neoplasms 1

Interventions

Tirzepatide 9Methods 8Educational Status 8Exercise 6Early Intervention, Educational 6Interviews as Topic 5Counseling 5semaglutide 3Surveys and Questionnaires 3Standard of Care 3Resistance Training 3Radiotherapy 3Nutrition Assessment 3naldemedine 2Transcutaneous Electric Nerve Stimulation 2Specimen Handling 2Progestins 2Mouthwashes 2Mindfulness 2Megestrol Acetate 2Letrozole 2Health Promotion 2Exercise Test 2Echocardiography 2Drug Therapy 2Diet Therapy 2Bupropion 2mirabegron 1ma zi ren wan 1isatuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Letrozole × Other × 1 year × Clear all
NCT07596212 2026-05-19

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

University of Illinois at Chicago

Phase 1/2 Not yet recruiting
100 enrolled
BreastOther

Breast Neoplasms, Sexual Dysfunctions, Psychological

NCT06379113 2025-08-11

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Fudan University

Phase 2/3 Recruiting
29 enrolled
GynecologicOther

Progesterone Resistance, Endometrial Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡